Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAN2 Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

AN2 Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 15, 2026Trenor Cameron C. IIIChief Medical Officer233,333Stock Option (right to by)$1.3MGrant / award
Sep 15, 2026Trenor Cameron C. IIIChief Medical Officer116,667Common Stock$631.2KGrant / award
Sep 9, 2026Readnour Robin ShaneDirector1,108Common Stock$6.5KSell
Sep 8, 2026Readnour Robin ShaneDirector10,019Common Stock$59KSell
Sep 3, 2026Readnour Robin ShaneDirector6,100Common Stock$34KSell
Sep 1, 2026Williams Sarah JoannePrincipal Accounting Officer272Common Stock$1.5KSell
Sep 1, 2026FitzPatrick Margaret MDirector2,098Common Stock$11.7KBuy
Aug 17, 2026Readnour Robin ShaneDirector35,402Common Stock$212.1KSell
Aug 14, 2026Zakrzewski Joseph SDirector405,880Common Stock$2.4MGift given
Jul 10, 2026Martin Patricia A.Director766Common Stock$3.4KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$5.07Close · Oct 6, 2026